Medication Management
Medication management is the ongoing clinical work of reviewing, reconciling, teaching, and monitoring a patient's medications across a home health episode. It is one of the highest-leverage activities in home care because medication problems drive a large share of avoidable emergency visits and rehospitalizations among home health patients.
What medication management includes in home health
The work spans the whole episode, not just admission:
- Reconciling the medication list at start of care, resumption of care, and after any transfer
- Completing the drug regimen review to catch clinically significant issues
- Assessing adherence and the patient's ability to self-administer
- Monitoring high-risk drugs such as anticoagulants, insulin, opioids, and diuretics
- Teaching purpose, dose, timing, and side effects
- Resolving discrepancies with prescribers and capturing changes as orders
Every discipline contributes, but the nurse completing the comprehensive assessment owns the baseline.
The OASIS drug regimen review requirement
OASIS requires a drug regimen review at start of care and resumption of care to identify clinically significant issues such as interactions, duplicate therapy, omissions, and adverse reactions. When an issue is found, the clinician must contact the physician or physician-designee and complete recommended actions by midnight of the next calendar day, and the OASIS items capture whether that happened. At transfer and discharge, OASIS also asks whether issues identified throughout the episode were addressed within that same timeframe. A missed follow-up is both a clinical risk and a measurable quality miss, so agencies need a reliable way to track open medication issues to closure.
High-risk drugs and polypharmacy
Most home health patients take multiple prescriptions, and risk concentrates in a familiar list: anticoagulants, insulin and other hypoglycemics, opioids, diuretics, and drugs with narrow therapeutic windows. A brown-bag review at admission, where the nurse physically inspects every bottle in the home, routinely surfaces duplicate brand and generic versions, discontinued drugs still being taken, and prescriptions from multiple prescribers who are unaware of each other. For polypharmacy patients, prioritize teaching on the two or three drugs where an error would cause harm fastest rather than skimming all fifteen.
What good looks like
A reconciled list that matches what is actually in the home, not just the hospital discharge paperwork. Discrepancies resolved with the prescriber and documented as orders. Teaching validated with teach-back and documented as demonstrated understanding, not a checked box. A visible trail from identified issue to physician contact to resolution within one calendar day. And at recertification or discharge, a current list with every verbal medication change captured as a signed order before the final claim is billed.
Frequently asked questions
Who can perform the drug regimen review in home health?
The clinician completing the comprehensive assessment, typically a registered nurse. In therapy-only cases, the physical therapist, occupational therapist, or speech-language pathologist completing the OASIS performs it. LPNs and aides cannot complete the comprehensive assessment.
What counts as a clinically significant medication issue?
Issues that pose a real threat to the patient: adverse reactions, dangerous interactions, duplicate therapy, omissions of needed drugs, dosage errors, and nonadherence that jeopardizes health. Clinical judgment applies, so document the rationale for what was and was not escalated.
Does the home health benefit pay for medications?
No. Prescription drugs are generally excluded from the home health benefit and are covered under Part D, or Part B for certain categories. The agency manages the regimen and the teaching, not the drug cost.